Boston Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.18M Hold
11,150
﹤0.01% 576
2025
Q1
$1.38M Buy
11,150
+1,978
+22% +$246K ﹤0.01% 529
2024
Q4
$1.13M Hold
9,172
﹤0.01% 556
2024
Q3
$1.02M Buy
9,172
+606
+7% +$67.5K ﹤0.01% 603
2024
Q2
$914K Sell
8,566
-628
-7% -$67K ﹤0.01% 597
2024
Q1
$1.11M Sell
9,194
-2,875
-24% -$346K ﹤0.01% 561
2023
Q4
$1.48M Buy
12,069
+2,141
+22% +$263K ﹤0.01% 524
2023
Q3
$1.29M Buy
9,928
+3,327
+50% +$431K ﹤0.01% 530
2023
Q2
$818K Hold
6,601
﹤0.01% 565
2023
Q1
$966K Buy
6,601
+825
+14% +$121K ﹤0.01% 526
2022
Q4
$920K Buy
5,776
+133
+2% +$21.2K ﹤0.01% 520
2022
Q3
$752K Buy
5,643
+114
+2% +$15.2K ﹤0.01% 544
2022
Q2
$862K Sell
5,529
-38,185
-87% -$5.95M ﹤0.01% 539
2022
Q1
$6.81M Sell
43,714
-521,660
-92% -$81.2M 0.01% 384
2021
Q4
$72M Sell
565,374
-4,435
-0.8% -$565K 0.09% 220
2021
Q3
$74.2M Buy
569,809
+12,777
+2% +$1.66M 0.09% 225
2021
Q2
$99M Buy
557,032
+8,053
+1% +$1.43M 0.13% 207
2021
Q1
$90.2M Sell
548,979
-428,447
-44% -$70.4M 0.12% 213
2020
Q4
$161M Buy
977,426
+2,824
+0.3% +$466K 0.25% 131
2020
Q3
$139M Sell
974,602
-1,254
-0.1% -$179K 0.25% 129
2020
Q2
$108M Sell
975,856
-301,745
-24% -$33.3M 0.2% 154
2020
Q1
$127M Sell
1,277,601
-60,461
-5% -$6.03M 0.25% 118
2019
Q4
$200M Sell
1,338,062
-26,820
-2% -$4M 0.26% 114
2019
Q3
$175M Buy
1,364,882
+23,859
+2% +$3.06M 0.24% 121
2019
Q2
$191M Buy
1,341,023
+35,360
+3% +$5.04M 0.25% 123
2019
Q1
$187M Sell
1,305,663
-9,708
-0.7% -$1.39M 0.25% 124
2018
Q4
$163M Buy
1,315,371
+198,306
+18% +$24.6M 0.23% 125
2018
Q3
$188M Buy
1,117,065
+27,409
+3% +$4.61M 0.22% 130
2018
Q2
$188M Buy
1,089,656
+18,821
+2% +$3.24M 0.23% 134
2018
Q1
$162M Sell
1,070,835
-128,353
-11% -$19.4M 0.2% 145
2017
Q4
$161M Buy
+1,199,188
New +$161M 0.19% 144